June 27, 2026 02:03 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Ram Mandir Trust chief Champat Rai resigns as alleged donation siphoning row escalates | Ram Mandir fund row deepens: 8 arrested days after BJP called allegations 'false narrative' | 'Who tied the hands of CBI?': Calcutta HC on RG Kar case; victim's mother, now BJP MLA, says she is 'deeply disturbed' | Construction comes to a standstill at nearly 700 Kolkata projects after Taratala warehouse tragedy kills 15 | World Cup shocker! Ecuador stun Germany 2-1, storm into Round of 32 | Iran-US conflict: Cargo vessel hit near Strait of Hormuz, UN agency pauses evacuation operations | Amazon's massive India bet! Andy Jassy announces $48 billion investment after meeting PM Modi | Taratala warehouse collapse: Death toll climbs to 8, five arrested as SIT launches probe | Oil prices crash, IndiGo takes off! Aviation and fuel stocks emerge as biggest winners | Passport is a travel document, not conclusive proof of citizenship: MEA
Pfizer
Image: Wikimedia Commons

Pfizer launches pilot COVID-19 vaccine distribution preparedness program in 4 US states

| @indiablooms | Nov 17, 2020, at 10:14 pm

Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavirus vaccine in the US states of Rhode Island, Texas, New Mexico and Tennessee.

"To build on our coordination with the relevant U.S. agencies, Pfizer launched this pilot program to help better support the states’ planning, deployment, and administration of the COVID-19 vaccine candidate. Learnings from this program will be adapted for usage across other states to help them create effective immunization programs for this vaccine," the company said in a press release.

According to Pfizer, the four US states were selected due to their differences in overall size, diversity of populations, and immunization infrastructure, as well as the need to reach populations both in rural and urban areas.

In a disclaimer of future preferential benefits for these four states, the company has stressed that they "will not receive vaccine doses earlier than other states by virtue of this pilot, nor will they receive any differential consideration."

Pfizer developed the vaccine in collaboration with German biotechnology company BioNTech. As the unregistered vaccine is underway with phase 3 clinical trials, the creators have declared above 90-percent efficiency.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.